Rexulti

Rexulti (brexpiprazole) is an antipsychotic. It is used in combination with antidepressants to treat major depressive disorder. It can also be used to treat schizophrenia and dementia-related agitation from Alzheimer's disease. There are currently no generic alternatives. While 83% of insurance plans cover the most common version of Rexulti at a co-pay of $60.00-$85.00, many of them have restrictions. Manufacturer and pharmacy coupons can help offset the cost.

With the Patient Assistance Program from Otsuka Patient Assistance Foundation, Inc., receive your prescription at no charge if you are eligible.